Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03171-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Ophthalmology, 2024. Verfasst von Şenol Sabancı und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Antalya Training and Research Hospital, Antalya, Turkey. sbncsenol@yahoo.com. Hauptthemen laut MEDLINE: Bevacizumab, Retinopathy of Prematurity, Intravitreal Injections, Angiogenesis Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To compare the results of intravitreal bevacizumab (IVB) monotherapy and combined intravitreal bevacizumab and laser photocoagulation (LPC) therapies applied in the same session to patients with aggressive retinopathy of prematurity (A-ROP) in our clinic. METHODS: The study included 67 eyes of 37 patients diagnosed with A-ROP and treated. Forty-nine eyes treated with anti-vascular endothelial growth factor agent injection monotherapy for A-ROP treatment were included in the first group. The second group consisted of 18 eyes that received injection therapy and LPC treatment. The clinical findings of the two groups were investigated, and their treatment results were compared. RESULTS: Recurrence was observed in 19 of the 49 (38%) eyes in the first group, but there was no recurrence in any of the cases in the second group. While only IVB was applied to eight cases with recurrence, the combination of LPC and IVB treatment was applied to 11 cases. A second recurrence was detected in two of the eight cases that had received IVB monotherapy as a treatment for recurrence and in three of the 11 cases that had received LPC and IVB. The treatment outcomes of the two groups did not statistically significantly differ (P = 0.181). CONCLUSION: We consider that the combined simultaneous LPC and IVB treatment we applied in A-ROP cases is an effective approach, particularly for cases where there are concerns about the patient's ability to attend follow-up appointments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Antalya Training and Research Hospital, Antalya, Turkey. sbncsenol@yahoo.com.
- Ophthalmology Department, Antalya Training and Research Hospital, Antalya, Turkey.
Zitieren
APA
Sabancı, Ş., Küçük, M. F., Süren, E., & Erol, M. K. (2024). Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity. International Ophthalmology. https://doi.org/10.1007/s10792-024-03171-0
Vancouver
Sabancı Ş, Küçük MF, Süren E, Erol MK. Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity. International Ophthalmology. 2024. doi:10.1007/s10792-024-03171-0
BibTeX
@article{Sabanc2024,
author = {Sabancı, Şenol and Küçük, Mehmet Fatih and Süren, Elçin and Erol, Muhammet Kazim},
title = {Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03171-0}
}
EUVIMED